IMVT CIK: 1764013

Immunovant, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
Change from FY23 to FY24
millions USD
FY22:
–
FY23:
10.0
FY24:
12.5
FY25:
–
FY26:
–
(positive)
Change from FY22 to FY26
millions USD
FY22:
−156
FY23:
−208
FY24:
−270
FY25:
−438
FY26:
−533
(positive)
Change from FY22 to FY26
millions USD
FY22:
−156
FY23:
−198
FY24:
−257
FY25:
−438
FY26:
−532
(positive)
Change from FY22 to FY26
millions USD
FY22:
−157
FY23:
−211
FY24:
−259
FY25:
−413
FY26:
−505
(positive)
Change from FY22 to FY26
millions USD
FY22:
−157
FY23:
−211
FY24:
−259
FY25:
−414
FY26:
−506

All amounts in millions USD Data sources:SEC EDGARTwelve Data